These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 2377612)

  • 1. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
    Maruyama K; Kennel SJ; Huang L
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of in vivo immunoliposome targeting to pulmonary endothelium.
    Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L
    J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions.
    Holmberg E; Maruyama K; Litzinger DC; Wright S; Davis M; Kabalka GW; Kennel SJ; Huang L
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1272-8. PubMed ID: 2610692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
    Litzinger DC; Huang L
    Biochim Biophys Acta; 1992 Feb; 1104(1):179-87. PubMed ID: 1550846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large liposomes containing ganglioside GM1 accumulate effectively in spleen.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1991 Jul; 1066(2):159-65. PubMed ID: 1854781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
    Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-immunoliposome.
    Maruyama K
    Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
    Allen TM; Hansen C
    Biochim Biophys Acta; 1991 Sep; 1068(2):133-41. PubMed ID: 1911826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition.
    Spanjer HH; van Galen M; Roerdink FH; Regts J; Scherphof GL
    Biochim Biophys Acta; 1986 Dec; 863(2):224-30. PubMed ID: 3790559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
    Nässander UK; Steerenberg PA; Poppe H; Storm G; Poels LG; De Jong WH; Crommelin DJ
    Cancer Res; 1992 Feb; 52(3):646-53. PubMed ID: 1732053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1992 Feb; 1104(1):95-101. PubMed ID: 1550858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of active targeting to tumor tissues with liposomes.
    Maruyama K; Ishida O; Takizawa T; Moribe K
    Adv Drug Deliv Rev; 1999 Nov; 40(1-2):89-102. PubMed ID: 10837782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse.
    Wang CY; Huang L
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7851-5. PubMed ID: 2446313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody targeting of liposomes to mouse lung in vivo.
    Hughes BJ; Kennel S; Lee R; Huang L
    Cancer Res; 1989 Nov; 49(22):6214-20. PubMed ID: 2478282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
    Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
    Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
    Mori A; Kennel SJ; Huang L
    Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
    Ng K; Zhao L; Liu Y; Mahapatro M
    Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.